Kidney stones constitute a disease of the urinary system of high incidence that has only a
few available stone dissolving drugs as treatment options. The mechanism of calcium …

Urolithiasis is a high‑incidence disease caused by calcium oxalate (mainly), uric acid,
calcium phosphate, struvite, apatite, cystine and other stones. The development of kidney …

Polyprotic acids often serve as effective regulators of inorganic crystallization in natural,
biological, and synthetic systems. These molecules or macromolecules can function as …

A novel urolithiasis treatment in which a chelating solution encapsulated in poly (lactic-co-
glycolic acid); PLGA-based microcapsules was delivered magnetically to specific urolithiasis …

Nanostructured, inorganic microspheres have many industrial applications, including
catalysis, electronics, and particularly drug delivery, with several advantages over their …

The large‐scale synthesis of calcium terephthalate (CaTP) and upcycling of poly (ethylene
terephthalate)(PET) are performed simultaneously by reactive processing. In the one‐pot …

An ultrasensitive sensor with excellent photoelectrochemical (PEC) properties was
developed based on the combination of electrostatic interactions between the …

Urolithiasis is one of most common renal disorders, characterized by the formation of kidney
stones (renal calculi) through the crystallization process within the urinary system. The …

Poly-anionic compounds can chelate divalent cations and dissolve calcium oxalate stone.
Our objective was to assess how much concurrent irrigation with poly-anionic chelating …

Hexametaphosphate (HMP) is an inorganic condensed phosphate, which has been used in
a wide variety of industries for nearly a century, originally patented to deflocculate clay and …